DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

References

Maertens JA, Raad II, Marr KA. , et al.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Lancet 2016;
387 (10020): 760-769

Download Bibliographical Data

Search in:
Access:
Access: